Compare BXBL & OMCL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BXBL | OMCL |
|---|---|---|
| Founded | N/A | 1992 |
| Country | United States | United States |
| Employees | 128 | N/A |
| Industry | Homebuilding | Computer Manufacturing |
| Sector | Consumer Discretionary | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.4B | 1.6B |
| IPO Year | 2023 | 2000 |
| Metric | BXBL | OMCL |
|---|---|---|
| Price | $3.36 | $34.21 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 6 |
| Target Price | N/A | ★ $55.83 |
| AVG Volume (30 Days) | 149.3K | ★ 458.4K |
| Earning Date | N/A | 04-28-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.77 |
| Revenue | N/A | ★ $787,309,000.00 |
| Revenue This Year | N/A | $6.77 |
| Revenue Next Year | N/A | $5.22 |
| P/E Ratio | ★ N/A | $43.64 |
| Revenue Growth | N/A | ★ 9.93 |
| 52 Week Low | $3.18 | $29.06 |
| 52 Week High | $5.42 | $51.84 |
| Indicator | BXBL | OMCL |
|---|---|---|
| Relative Strength Index (RSI) | 36.58 | 46.61 |
| Support Level | N/A | $32.11 |
| Resistance Level | $4.49 | $35.61 |
| Average True Range (ATR) | 0.25 | 0.89 |
| MACD | -0.02 | 0.30 |
| Stochastic Oscillator | 10.84 | 82.28 |
BOXABL Inc is engaged in building construction using modern manufacturing processes to create residential and commercial buildings that can be completed in less time and at lower cost than traditional construction. The Company has developed a building system using manufacturing processes and existing technologies and processes developed by the automotive industry. Its products include the Casita and other building solutions using patented folding and shipping technology to transport buildings on existing roadways across large geographic areas.
Omnicell Inc provides automation and business analytics software for healthcare providers. The company is engaged in transforming the pharmacy and nursing care delivery model. The company helps its customers define and deliver cost-effective medication management designed to equip and empower pharmacists and nurses to focus on patient care rather than administrative tasks and drive improved clinical, operational, and financial outcomes across all care settings. The company derives the majority of its revenue from the United States.